http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b57c4d8e93ae49e9fb0c9f337c0fc21
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | de Braud Braud |
| name | Filippo de Braud |
| given-name | Filippo de Filippo |
| organization-name | Medical Oncology Department, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy; Oncology and Haemato-Oncology Department, University of Milan, Italy Medical Oncology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Medical Oncology & Hematology, University of Milan, Milan, Italy Medical Oncology Department Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy; Oncology and Hemato‐Oncology Department University of Milan Milan Italy Department of Medical Oncology; Fondazione IRCCS Istituto Nazionale Tumori; Milan 20133 Italy Department of Medical Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan - Italy Medical Oncology Department - National Cancer Institute of Milan - Fondazione IRCCS Istituto Nazionale Tumori, Milan - Italy; Medical Oncology Department, University of Milan, Milan - Italy 4START Project, European Institute of Oncology; University of Milan, Milan, Italy Medical Oncology Unit 1, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; 8Department of Oncology, Università degli Studi di Milano, Milan, Italy. Department of Medical Oncology, Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy (Divisione di Oncologia Medica B, Istituto Nazionale per la Cura e lo Studio dei Tumori, Milano) Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Inter-Hospital Pathology Division, Science and Technology Park, IRCCS MultiMedica, Milan, Italy Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy Department of Medical Oncology; Fondazione IRCCS Istituto Nazionale dei Tumori; Milan Italy; Università degli Studi di Milano; Milan Italy Medical Oncology Department Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Italy; Department of Oncology and Hemato‐Oncology University of Milan Italy Istituto Nazionale dei Tumori, Milan, Italy Clinical Pharmacology and New Drug Development Unit, Division of Medical Oncology, European Institute of Oncology, Milano, Italy Department of Medical Oncology, Unit 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133, Milan, Italy Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Department of Medical Oncology, Unit of Thoracic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via G Venezian 1, 20133 Milan, Italy; Department of Medical Oncology & Hematology, University of Milan, via Festa del Perdono 7, 20122 Milan, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Milan, Italy; University of Milan, Milan, Italy 1Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; 26Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Yelena Y. Janjigian, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Johanna Bendell, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN; Emiliano Calvo, START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain; Joseph W. Kim, Yale Cancer Center, New Haven, CT; Paolo A. Ascierto, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples; Filippo de Braud, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan,... From the Divisions of Medical Oncology, Pathology, Thoracic Surgery, Epidemiology and Biostatistics, and Radiotherapy, European Institute of Oncology, Milan; and Division of Pharmacology and Chemotherapy, University of Pisa, Pisa, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Milan, Italy; Department of Oncology and Hemato-Oncology, Università deli Studi di Milano, Milan, Italy Department of Medical Oncology Unit 1, GEP-ENETS Center of Excellence, “Istituto Nazionale Tumori”, Milan, Italy; University of Milan, Fondazione IRCCS “Istituto Nazionale dei Tumori”, Via G. Venezian 1, 20133 Milan, Italy 1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; 3Universita' degli Studi di Milano, Milan, Italy. Authors' Affiliations: 1Department of Dermatology, University Medical Center, Tübingen, Germany; 2Clinical Pharmacology and New Drugs Development Unit, European Institute of Oncology, Milan; 3Department of Oncology, Division of Medical Oncology, S. Chiara Hospital, Pisa; 4Philogen SpA, La Lizza, Siena, Italy; 5Philochem AG, Otelfingen; and 6Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland Department of Medical Oncology, Fondazione IRCCS Istituto Tumori Milano, Milan, Italy; Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy Medical Oncology Department, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan - Italy; Medical Oncology Department, University of Milan, Milan - Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy; Department of Oncology, Università degli Studi di Milano, Milan - Italy Istituto Nazionale Tumori di Milano, Milano, Italy 7Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; 8University of Milan, Milan, Italy. Department of Oncology & Hemato-Oncology, University of Milan, Via Santa Sofia 9/1, Milan, 20122, Italy; Department of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy Department of Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Medical Oncology Unit 1, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; 4Oncology and Haemato-Oncology Department, University of Milan, Milan, Italy. 6Department of Medical Oncology, Fondazione IRCCS Istituto Tumori Milano, Department of Oncology, Università degli Studi di Milano, Milan, Italy. Fondazione Instituto di Ricovero e Cura Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, Milan, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Oncology and Hemato-oncology Department, University of Milan, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy From the University Hospital, Hamburg-Eppendorf; South West German Comprehensive Cancer, University Hospital Tübingen, Tübingen; Merck Serono, Darmstadt Germany; State Medical Academy, City Clinical Hospital #4, Dnepropetrovsk, Ukraine; Moscow City Oncology Hospital #62, Moscow Area, Russian Federation; Hospital Universitario La Fe, Valencia, Spain; Istituto Europeo di Oncologia, Milan, Italy; Institutul Oncologic “Prof. Dr. Al. Trestioreanu” Bucuresti, Bucharest, Romania; Wilhelminenspital der Stadt... Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy; Department of Oncology & Hemato-oncology, University of Milan, Milan, Italy Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milan Italy; Department of Oncology and Hemato‐Oncology University of Milan Milan Italy Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy Fondazione IRCCS “Istituto Nazionale dei Tumori,” Milan, Italy Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy Department of Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy; Medical Oncology and Hematology Department, Istituto Nazionale dei Tumori, Milan, Italy Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, Italy Medical Oncology 1, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy 1Oncology and Hemato-oncology Department, University of Milan, Milan, Italy.; 2Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. National Cancer Institute Milan Italy Hans-Joachim Schmoll, Martin Luther University, Halle, Germany; Josep Tabernero, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain; Jean Maroun, Ottawa Regional Cancer Center, Ottawa, Ontario, Canada; Filippo de Braud, Istituto Europeo di Oncologia, Milan, Italy; Timothy Price, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia; Eric Van Cutsem, University Hospital Gasthuisberg, Leuven, Belgium; Mark Hill, Kent Oncology Centre, Maidstone, Kent, United... Medical Oncology Department Fondazione IRCCS – Istituto Nazionale dei Tumori Milan Italy; School of Medicine University of Milan Milan Italy Medical Oncology Department Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy Department of Medical Oncology, Unit 1, ENET Center of Excellence, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milan, Italy Department of Medical Oncology, ENETS Center of Excellence, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, Milan, Italy Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Medical Oncology Department, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Dept. of Oncology and Hemato‐oncology University of Milano Italy; Division of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy Fondazione IRCCS Istituto Nazionale dei Tumori, Università di Milano. Clinical Pharmacology & New Drugs Unit, Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy Ordinario di Oncologia Medica Direttore Scuola di Specialità in Oncologia Medica Università di Milano, Direttore Dipartimento Oncologia e Ematoncologia Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Oncology and Hemato-oncology Department, University of Milan, Milan, Italy Medical Oncology Department Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy; Department of Oncology and Hemato‐Oncology Università degli Studi di Milano Milan Italy Division of Medical Oncology B, Istituto Nazionale per lo Studio e la Cura del Tumori, Milan, Italy Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, Università deli Studi di Milano, Milan, Italy. Division of Medical Oncology « B », Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano 1Department of Medical Oncology ENETS Center of Excellence, Fondazione IRCCS Istituto Tumori Milano, Milan, Italy; 8Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Fondazione IRCCS Istituto Nazionale Tumori Milano, ENETS Center of Excellence, Department of Medical Oncology, Milan, Italy 1Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; 9Department of Oncology, University of Milan, Milan, Italy. Departments of Medical Oncology, Pathology, and Thoracic Surgery, European Institute of Oncology, Milan, Italy Oncology and Hemato-oncology Department, University of Milan, Milan, Italy; Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy Department of Meical Oncology, Fondazione IRCCS Istituto Nazionale Tumori Milan Italy Division of Cancer Chemotherapy, National Cancer Institute, Milano, Italy Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy (Division of Medical Oncology « B », Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano) 1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; 10Oncology and Haemato-Oncology Department, University of Milan, Università degli Studi di Milano, Milan, Italy. Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy Medical Oncology Department Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori Milan Italy; Oncology and Haemato‐Oncology Department University of Milan Milan Italy IRCCS National Cancer Institute Foundation, Milan, Italy From the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Vall d'Hebron University Hospital, Barcelona, Spain; Ottawa Regional Cancer Center, Ottawa, Canada; Istituto Europeo di Oncologia, Milan, Italy; The Queen Elizabeth Hospital, Adelaide, Australia; University Hospital Gasthuisberg, Leuven, Belgium; Kent Oncology Centre, Maidstone, Kent, United Kingdom; F. Hoffmann-La Roche, Basel, Switzerland; F. Hoffmann-La Roche, Nutley, NJ; and Martin Luther University, Halle, Germany. Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Università degli Studi di Milano, Milan, Italy Department of Oncology and Hemato‐Oncology University of Milan and Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale Tumori Milan Italy |
Incoming Links
Total number of triples: 439.